OncoBEAM™ RAS CRC Kit offers the following advantages:

  • High Concordance with Tissue OncoBEAM™ RAS CRC Kit demonstrated an overall percent agreement of 93.3 % with tissue
  • Safety and Convenience Minimally invasive, few risks
  • Accurate Information Blood sample evaluation represents current mutational status of patient’s disease; Information of tumor dynamics in real time
  • No Selection Bias Evaluate primary tumor and metastases with one sample
  • Ability to Monitor Allows multiple measurements to assess drug response and resistance
  • Time Sensitive Rapid turnaround time from biopsy to result

Please help us to serve you better by sharing your experience.

Do you find the resources provided at this site useful?

What scientific topics you would be most interested to read?